Concepedia

Jung Ho Back

JH

Statistics

Publications

8

Citations

321

H-Index

8

Active since

2010

Affiliations

Columbia University Irving Medical Center(Current)

University of Alabama at Birmingham

Inserm

Cancer Research Center

Jung Ho Back is an author at Columbia University Irving Medical Center specializing in molecular oncology, oncology, and cancer cell signaling.

Publications per year

2010–2018

8

Publications

8

Cancer Cell Survival Following DNA Damage-mediated Premature Senescence Is Regulated by Mammalian Target of Rapamycin (mTOR)-dependent Inhibition of Sirtuin 1

Jung Ho Back, Hamid Rezvani, Yucui Zhu et al. · Journal of Biological Chemistry · 2011 · 86 citations · Full text

, , +17

Resveratrol Targets Transforming Growth Factor-β2 Signaling to Block UV-Induced Tumor Progression

Kwang Ho Kim, Jung Ho Back, Yucui Zhu et al. · Journal of Investigative Dermatology · 2010 · 59 citations

, , +12

Resveratrol‐Mediated Downregulation of Rictor Attenuates Autophagic Process and Suppresses UV‐Induced Skin Carcinogenesis<sup>†</sup>

Jung Ho Back, Yucui Zhu, Alyssa Calabro et al. · Photochemistry and Photobiology · 2012 · 51 citations · Full text

, , +17

Inhibition of p38 MAPK Signaling Augments Skin Tumorigenesis via NOX2 Driven ROS Generation

Liang Liu, Hamid Rezvani, Jung Ho Back et al. · PLoS ONE · 2014 · 44 citations · Full text

, , +17

SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas

Arianna L. Kim, Jung Ho Back, Sandeep Chaudhary et al. · Journal of Investigative Dermatology · 2018 · 32 citations · Full text

, , +14

1–5 of 8